Documentary AreaSimply the best Documentaries

At the heart of the film is a simple proposition: what is a good society, and what role does the widening income gap play in the deterioration of the nations's economic health? We are endeavoring for Inequality for All to be a paradigm-shifting, eye-opening experience for the public. We want to accurately show through a non-partisan perspective why extreme income inequality is such an important topic for our citizens today and for the future.

Zeitgeist Addendum attempts to locate the root causes of this pervasive social corruption, while offering a solution. This solution is not based on politics, morality, laws, or any other 'establishment' notions of human affairs, but rather on a modern, non-superstitious based understanding of what we are and how we align with nature, to which we are a part. The work advocates a new social system which is updated to present day knowledge, highly influenced by the life long work of Jacque Fresco and The Venus Project.

A feature length documentary work which presents a case for a needed transition out of the current socioeconomic monetary paradigm which governs the entire world society. This subject matter will transcend the issues of cultural relativism and traditional ideology and move to relate the core, empirical 'life ground' attributes of human and social survival, extrapolating those immutable natural laws into a new sustainable social paradigm called a 'Resource-Based Economy'.

Trade, and in particular trade in luxury goods, drove the commerce economies of the Bronze Age. This is the time when the first super powers in history, Egypt and Mesopotamia, emerge and dominate the 'world' stage of the Mediterranean and Aegean seas and surrounding areas.

Targeting unsuspecting Americans, a group of payday lenders made millions off small loans with undisclosed charges, inflated interest rates and incomprehensible rules. But the way the laws are written, is that a crime or just business?

Valeant Pharmaceuticals was a multinational specialty pharmaceutical company based in Canada. It grew rapidly through a series of mergers and acquisitions under the leadership of J. Michael Pearson. The company was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs, which led to an investigation by the U.S. Securities and Exchange Commission and caused its stock price to plummet more than 90 percent from its peak while its debt surpassed $30 billion.
Wall Street short-sellers exposed a scam that regulators overlook: how Big Pharma gouges patients in need of life-saving drugs.